ZOTA HEALTH CARE LIMITED
ZOTA · General/Diversified · NSE
₹1,214
Current Market Price
Fair Value (DCF)
₹1,214
Discount to FV
+0.0%
Updated 3h ago
YieldIQ Score
40/100
Piotroski F-Score
3/9
Economic Moat
None
Confidence
8%
ROE
-24.8%
Debt/Equity
0.61
WACC
11.1%
Market Cap
₹3,683 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
-1.5%
Return on capital employed
EV / EBITDA
—
Enterprise multiple
Debt / EBITDA
—
Leverage vs earnings
Interest Coverage
-5.4×
EBIT covers interest
Current Ratio
1.83×
Short-term liquidity
Asset Turnover
0.94×
Revenue per ₹ of assets
Revenue CAGR (3Y)
56.7%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹1,214.2
Bear case
Discount -Infinity%
Base case
Discount +0.0%
Bull case
Discount +16.7%
Ratio Trends
ZOTA · last 4 annual periods
ROE
-24.8%
ROCE
-1.5%
Operating Margin
—
Debt / Equity
0.61×
PE
101.3×
EV / EBITDA
92.3×
Historical Financials
ZOTA · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹131 Cr | ₹140 Cr | ₹180 Cr | ₹293 Cr | ₹539 Cr | +42.3% |
| EBITDA | ₹16.4 Cr | ₹9.8 Cr | ₹8.2 Cr | ₹-3.7 Cr | ₹20.0 Cr | +5.1% |
| EBIT | ₹12.8 Cr | ₹-2.1 Cr | ₹-11.4 Cr | — | — | — |
| PAT | ₹8.9 Cr | ₹-5.8 Cr | ₹-14.3 Cr | ₹-56.4 Cr | ₹-73.9 Cr | — |
| EPS (diluted) | ₹3.58 | ₹-2.29 | ₹-5.47 | — | — | — |
| CFO | ₹13.3 Cr | ₹-2.0 Cr | ₹-6.0 Cr | ₹-50.0 Cr | ₹-84.4 Cr | — |
| CapEx | ₹-3.2 Cr | ₹-12.5 Cr | ₹-16.7 Cr | ₹-46.0 Cr | ₹-113 Cr | — |
| FCF | ₹10.1 Cr | ₹-14.5 Cr | ₹-22.7 Cr | ₹-95.9 Cr | ₹-197 Cr | — |
| Total Assets | ₹139 Cr | ₹158 Cr | ₹228 Cr | ₹439 Cr | ₹1131 Cr | +68.9% |
| Total Debt | ₹14.9 Cr | ₹45.1 Cr | ₹95.3 Cr | ₹140 Cr | ₹270 Cr | +106.4% |
| Shareholders' Equity | ₹89.6 Cr | ₹80.4 Cr | ₹90.0 Cr | ₹224 Cr | ₹693 Cr | +66.8% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
ZOTA vs 2 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
DCAL DCAL | — | — | Pending | 1.5% | — |
 PANACEABIO PANACEABIO | — | — | Pending | -1.0% | — |
Click a ticker to view its fair-value analysis.
Dividend History
9 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹5.50/sh
Last payout
2025-09-22
₹1.00
Peak payout
₹2.14
Trailing yield
0.08%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. ZOTA HEALTH CARE LIMITED (ZOTA.NS) trades at 1214.20 vs a model fair value of 1214.20, a gap of 0.0%. Piotroski F-score: 3/9. Moat label:...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of ZOTA →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for ZOTA →
Compare
Head-to-head with peers
Compare ZOTA side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse ZOTANow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.